-
Something wrong with this record ?
Comparative analysis of antibiotic prophylaxis guidelines in cardiac surgery: a survey in Czechia and Slovakia
V. Kubíčková, M. Poruba, M. Halačová
Language English Country England, Great Britain
Document type Journal Article, Comparative Study
- MeSH
- Anti-Bacterial Agents * therapeutic use administration & dosage MeSH
- Antibiotic Prophylaxis * standards statistics & numerical data MeSH
- Surgical Wound Infection * prevention & control MeSH
- Cardiac Surgical Procedures * MeSH
- Humans MeSH
- Hospitals statistics & numerical data MeSH
- Surveys and Questionnaires MeSH
- Practice Guidelines as Topic MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Comparative Study MeSH
- Geographicals
- Czech Republic MeSH
- Slovakia MeSH
BACKGROUND: Surgical site infections (SSIs) in cardiac surgery significantly impact patient outcomes. This study examines cardiac antimicrobial prophylaxis guidelines in Czech and Slovak hospitals, crucial for reducing SSI incidence. METHODS: An electronic survey was conducted across cardiac surgery departments in both countries, focusing on surgical antibiotic prophylaxis (SAP) protocols, antibiotic choices, dosages, timing and postoperative infection rates. Responses were collected over three months, ensuring a comprehensive overview. FINDINGS: Most surveyed hospitals (79%) implement SAP, but guidelines exhibit notable variability. Cefazolin dominates as the primary prophylactic choice, with varying dosing regimens. Challenges include timing inconsistencies and prolonged prophylaxis durations, particularly in implant-related procedures. Regular guideline revisions are reported in 18% of hospitals within the last year, emphasizing the need for updated practices. CONCLUSIONS: This study shows the importance of standardizing SAP practices, aligning them with evolving evidence, and implementing regular guideline revisions. The observed variations highlight opportunities for enhanced SSI prevention strategies in cardiac surgery, ultimately contributing to improved patient outcomes.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25010067
- 003
- CZ-PrNML
- 005
- 20250429134703.0
- 007
- ta
- 008
- 250415e20241213enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jhin.2024.11.019 $2 doi
- 035 __
- $a (PubMed)39675571
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Kubíčková, V $u Department of Pharmacology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic
- 245 10
- $a Comparative analysis of antibiotic prophylaxis guidelines in cardiac surgery: a survey in Czechia and Slovakia / $c V. Kubíčková, M. Poruba, M. Halačová
- 520 9_
- $a BACKGROUND: Surgical site infections (SSIs) in cardiac surgery significantly impact patient outcomes. This study examines cardiac antimicrobial prophylaxis guidelines in Czech and Slovak hospitals, crucial for reducing SSI incidence. METHODS: An electronic survey was conducted across cardiac surgery departments in both countries, focusing on surgical antibiotic prophylaxis (SAP) protocols, antibiotic choices, dosages, timing and postoperative infection rates. Responses were collected over three months, ensuring a comprehensive overview. FINDINGS: Most surveyed hospitals (79%) implement SAP, but guidelines exhibit notable variability. Cefazolin dominates as the primary prophylactic choice, with varying dosing regimens. Challenges include timing inconsistencies and prolonged prophylaxis durations, particularly in implant-related procedures. Regular guideline revisions are reported in 18% of hospitals within the last year, emphasizing the need for updated practices. CONCLUSIONS: This study shows the importance of standardizing SAP practices, aligning them with evolving evidence, and implementing regular guideline revisions. The observed variations highlight opportunities for enhanced SSI prevention strategies in cardiac surgery, ultimately contributing to improved patient outcomes.
- 650 12
- $a antibiotická profylaxe $x normy $x statistika a číselné údaje $7 D019072
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a infekce chirurgické rány $x prevence a kontrola $7 D013530
- 650 12
- $a kardiochirurgické výkony $7 D006348
- 650 12
- $a antibakteriální látky $x terapeutické užití $x aplikace a dávkování $7 D000900
- 650 _2
- $a průzkumy a dotazníky $7 D011795
- 650 _2
- $a směrnice pro lékařskou praxi jako téma $7 D017410
- 650 _2
- $a nemocnice $x statistika a číselné údaje $7 D006761
- 651 _2
- $a Slovenská republika $7 D018154
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a srovnávací studie $7 D003160
- 700 1_
- $a Poruba, M $u Department of Pharmacology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic. Electronic address: martin.poruba@upol.cz
- 700 1_
- $a Halačová, M $u Department of Clinical Pharmacy, Na Homolce Hospital, Prague, Czech Republic; Department of Anaesthesia and Intensive Care Medicine, Charles University, Third Faculty of Medicine and FNKV University Hospital, Prague, Czech Republic; Department of Pharmacology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
- 773 0_
- $w MED00002716 $t The Journal of hospital infection $x 1532-2939 $g Roč. 156 (20241213), s. 64-71
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39675571 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429134659 $b ABA008
- 999 __
- $a ok $b bmc $g 2311436 $s 1247148
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 156 $c - $d 64-71 $e 20241213 $i 1532-2939 $m The Journal of hospital infection $n J Hosp Infect $x MED00002716
- LZP __
- $a Pubmed-20250415
